首页> 外文期刊>Journal of Health, Medicine and Nursing >Evaluation of Hepatocellular Carcinoma by Gadolinium- Based Contrast Media on MRI
【24h】

Evaluation of Hepatocellular Carcinoma by Gadolinium- Based Contrast Media on MRI

机译:基于Gadolinium的造影剂对MRI的肝细胞癌评估

获取原文
           

摘要

Hepatocellular carcinoma (HCC) is a big cause of death associated with cancer in the world and is the most common liver malignancy. More prevalence of chronic hepatitis virus (primarily chronic hepatitis B and hepatitis C) is attributed to high prevalence in Asia. Purpose: The purpose of this research was to test gadolinium-based contrast media for hepatocellular carcinoma on MRI.A total of 96 patients from Lahore who visited at radiology department of Al Razi Health Care Hospital from August 2020 to November 2020 for the evaluation of hepatocellular carcinoma by gadolinium based contrast media on MRI. Results: The study was conducted on 96 patients for the evaluation of hepatocellular carcinoma, out of which 62 were diagnosed with hepatocellular carcinoma. HCC have become a major burden in the world increasing mortality and morbidity. Early identification leads to early treatment and improved survival.
机译:肝细胞癌(HCC)是与世界上癌症相关的重要原因,是最常见的肝病恶性肿瘤。慢性肝炎病毒(主要慢性乙型肝炎和丙型肝炎)的患病率归因于亚洲的普遍存在。目的:本研究的目的是测试肝细胞癌的基于Gadolinium的造影剂MRI.A从8月20日至11月20日至11月20日开始在Al Razi卫生保健医院放射科患者中获得96名患者。评估肝细胞癌基于Gadolinium基于MRI的造影剂的癌。结果:该研究于96名患者进行肝细胞癌评估,其中62例被诊断为肝细胞癌。 HCC已成为世界上增加死亡率和发病率的重大负担。早期鉴定导致早期治疗和提高存活。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号